Qube Research & Technologies LTD Outset Medical, Inc. Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Outset Medical, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 208,106 shares of OM stock, worth $126,944. This represents 0.0% of its overall portfolio holdings.
Number of Shares
208,106
Previous 37,967
448.12%
Holding current value
$126,944
Previous $84,000
853.57%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding OM
# of Institutions
131Shares Held
39MCall Options Held
65.1KPut Options Held
91.3K-
Ameriprise Financial Inc Minneapolis, MN5.2MShares$3.17 Million0.01% of portfolio
-
Morgan Stanley New York, NY3.82MShares$2.33 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY3.07MShares$1.87 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.65MShares$1.61 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.94MShares$1.19 Million0.0% of portfolio
About Outset Medical, Inc.
- Ticker OM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 48,007,300
- Market Cap $29.3M
- Description
- Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...